On the other hand, Ogiso and colleagues reported that IDO deficiency aggravated liver fibrosis in CCl4-treated mice [30], and another study reported that IDO inhibition mitigated the anti-fibrotic effect of mesenchymal stem cells in CCl4-treated mice [31]. Here, IDO1 is linked to Hepatic fibrosis.